Libo Chen
Impact in
-
- Thyroid Cancer Diagnosis and Treatment
- Thyroid Disorders and Treatments
Papers in
-
- Thyroid Cancer Diagnosis and Treatment 20
- Oncology 3
- Cancer Diagnosis and Treatment 2
- Co-authors
- Yuchen Jin (7 shared papers)Min Liu (4 shared papers)Hankui Lu (6 shared papers)Ruisen Zhu (6 shared papers)Quan‐Yong Luo (7 shared papers)Yan Shen (5 shared papers)Yongli Yu (5 shared papers)Maomei Ruan (5 shared papers)
- Journals
- Thyroid (6 papers)Critical Reviews in Oncology/Hematology (2 papers)Pharmaceuticals (1 paper)Frontiers in Endocrinology (1 paper)Journal of Thrombosis and Thrombolysis (1 paper)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Libo Chen
23 papers receiving 293 citations
Peers
Comparison fields: 5 of 48
- Endocrinology, Diabetes and Metabolism 216
- Cancer Research 24
- Oncology 43
- Radiology, Nuclear Medicine and Imaging 36
- Internal Medicine 3
Countries citing papers authored by Libo Chen
This map shows the geographic impact of Libo Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Libo Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Libo Chen more than expected).
Fields of papers citing papers by Libo Chen
This network shows the impact of papers produced by Libo Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Libo Chen. The network helps show where Libo Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Libo Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 62 | |
| 2 | 2010 | 44 | |
| 3 | 2012 | 30 | |
| 4 | 2006 | 23 | |
| 5 | 2019 | 19 | |
| 6 | 2018 | 17 | |
| 7 | 2022 | 15 | |
| 8 | 2014 | 13 | |
| 9 | 2023 | 12 | |
| 10 | 2019 | 10 | |
| 11 | 2020 | 9 | |
| 12 | 2014 | 9 | |
| 13 | 2013 | 8 | |
| 14 | 2023 | 7 | |
| 15 | 2009 | 5 | |
| 16 | 2008 | 5 | |
| 17 | Clinical study of 312 cases with matastatic differentiated thyroid cancer treated with large doses of 131I. | 2005 | 5 |
| 18 | 2019 | 4 | |
| 19 | 2022 | 4 | |
| 20 | 2012 | 3 |
About Libo Chen
Libo Chen is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology, Surgery, Molecular Biology and Epidemiology, having authored 25 papers that have together received 307 indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (20 papers), Cancer Diagnosis and Treatment (2 papers), RNA modifications and cancer (2 papers), Thyroid and Parathyroid Surgery (2 papers), Radiomics and Machine Learning in Medical Imaging (1 paper), Venous Thromboembolism Diagnosis and Management (1 paper), Epigenetics and DNA Methylation (1 paper) and BRCA gene mutations in cancer (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (216 citations), Cancer Research (24 citations), Oncology (43 citations), Radiology, Nuclear Medicine and Imaging (36 citations) and Internal Medicine (3 citations). Libo Chen has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Yuchen Jin, Min Liu, Hankui Lu, Ruisen Zhu, Quan‐Yong Luo, Yan Shen, Yongli Yu, Maomei Ruan, Douglas Van Nostrand and Hao Fu. Their work appears in journals such as Thyroid, Critical Reviews in Oncology/Hematology, Pharmaceuticals, Frontiers in Endocrinology and Journal of Thrombosis and Thrombolysis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.